It is a necessary requirement by regulatory agencies for any product that is utilized by humans or animals to ensure microbial contamination. MLT is performed on a variety of pharmaceutical ingredients, medical devices, and non-sterile packaging from raw materials to the finished form of the product in order to determine the microbial load. Analysis is performed by our experts according to the strict guidelines and procedures outlined in USP<61>, USP <60> and USP<62>. USP<61>analysis quantifies the total aerobic microbial count and total yeast and mold count in a product being tested, while USP<62> allows for the detection of potential pathogens within a sample and USP <60> allows for the detection of Burkholderia cepacia Complex. Accuon Labs is capable to perform microbial limit testing as per USP <2021> and <2022> for nutraceuticals.
It is utilized to determine the effectiveness of preservatives added to nonsterile/sterile aqueous pharmaceutical products. These preservatives aid in preventing microbes that may inadvertently be introduced through the process of production or repeatedly withdrawing individual doses. The AET is also useful in determining whether the product’s preservative will maintain effectiveness throughout the shelf life or until expiration.
Completing the test requires inoculation of the product with a known quantity of various microorganisms. Effectiveness of the preservative is measured at varying times over the course of the next 28 days by comparing the known quantity of microorganisms introduced to the recorded quantities over the course of the testing period. We provide analysis for injections housed in multi-dose packaging, and for samples containing antimicrobial preservatives. Our scientists complete all analysis according to the processes and guidelines outlined within USP <51>, to ensure that all regulatory requirements are met for your product.
Environmental monitoring ensures the effectiveness of your cleaning and disinfecting processes and procedures. We are able to analyze the quality of air and surfaces within your manufacturing facility clean rooms and controlled environments following the guidelines set forth within USP<1116>. Our scientists can ensure that microbial levels will be controlled within the manufacturing environment allowing for confidence in the manufacturing of your product and reducing risk.
Following a comprehensive analyses, our experts will work closely with you in implementing an environmental monitoring program in order to keep your facility operating under the guidelines outlined under USP<1116>. We can provide you with a monitoring program that is all encompassing, ranging from, air, surface, and water quality, personnel training, and cleaning processes.
To verify the concentration of the active pharmaceutical ingredients (API) to determine the effectiveness of the product to inhibit growth of microorganisms. FDA regulations require that potency testing be performed on all products prior to release and that the potency specifications on the product label conform to the actual potency of the product. We perform all potency assays according to the processes set forth in USP<81> following cGMP standards. Methodologies we use in determining antibiotic potency include the cylinder plate and the turbidimetric assays. Strict controls are employed in both methods ensuring our clients they will receive the most precise and accurate reports following analysis.
Accuon is an expertise in microbiology testing & pharmaceutical testing, providing Endotoxin Testing services to detect and quantify gram-negative bacterial endotoxins by Chromogenic methods utilize a synthetic substrate which is added to the lysate. The reagent used by Accuon has the substrate co-lyophilized with the LAL reagent, which enables it to be used for all chromogenic methods. When chromogenic LAL reagents react with endotoxin, the cascade is initiated, and clotting enzyme is activated as in the other methods. The reactions proceed more rapidly at higher endotoxin concentrations.
Accuon is using Sievers Eclipse instrument to detect endotoxin content in a sample while meeting all requirements of the harmonized pharmacopoeia: USP <85>, EP 2.6.14 and JP 4.01. Through groundbreaking technology, the Eclipse platform significantly decreases pipetting steps, reduces operator-to-operator variability, and simplifies assay setup. The Eclipse platform (Sensitivity down to 0.005 EU/mL) leverages precise microfluidic liquid handling and embedded endotoxin to automate kinetic chromogenic assays.
Accuon provides USP <71> Sterility Testing of sterile pharmaceutical products, medical devices and water. Sterility testing is required during the sterilization validation process as well as for routine release testing.
All sterile samples are prepared and inoculated in ISO 5 hoods in ISO 7 clean rooms, to eliminate laboratory contamination. We can test sterile product with Membrane filtration and Direct inoculation methods.
Accuon Labs performs growth promotion testing to confirm that each lot of media can support growth of the six microorganisms stated in USP <71> Sterility Tests.Prior to conducting a USP <71> sterility test, our laboratory performs method suitability for each specific product formulation to ensure that an appropriate method is chosen for testing.
© 2023 Accuon Labs Inc. All rights reserved.
Accuon Labs Inc.
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to